AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES; OCCLUDER, PATENT DUCTUS, ARTERIOSUS
|
Back to Search Results |
|
Model Number 9-PDA2AS-05-04-L |
Device Problems
Improper or Incorrect Procedure or Method (2017); Obstruction of Flow (2423)
|
Patient Problem
Obstruction/Occlusion (2422)
|
Event Type
Injury
|
Manufacturer Narrative
|
As reported in a research article, aortic obstruction and left pulmonary artery obstruction was noted during follow up after implantation with a 5-6 amplatzer piccolo.The results of the investigation are inconclusive since the device was not returned for analysis.A review of the measurements as reported from the field was performed.Per the sizing table in the instructions for use, arten600042307 version a, the correct size piccolo occluder for the measurements provided was 04-02, smaller than the implanted device.The cause of the reported event could not be conclusively determined, however the implantation of a larger than recommended device could have contributed.
|
|
Event Description
|
Reference manufacturing report number: 2135147-2020-00091, 2135147-2020-00092, 2135147-2020-00093, 2135147-2020-00094.It was reported through a research article identifying amplatzer piccolo that may be related to a severe left pulmonary artery obstruction.Details are listed in the article, titled "device deformation and left pulmonary artery obstruction after transcatheter patent ductus arteriosus closure in preterm infants." it was reported in the article that in (b)(6) 2016, 14 patients underwent transcatheter patent ductus arteriosus (pda) closure.An 20 days old patient that weight 1672 grams with pda diameter of 2.95mm and pda length of 8.02mm was implanted with a 5-6 amplatzer piccolo.During follow up, aortic obstruction and severe left pulmonary artery obstruction was observed.The patient was asymptomatic and no intervention was performed.
|
|
Manufacturer Narrative
|
Correction information for b5, d1, d4, g4, g7, and h10.As reported in a research article, aortic obstruction and left pulmonary artery obstruction was noted during follow up after device implantation.The results of the investigation are inconclusive since the device was not returned for analysis.The cause of the reported event could not be conclusively determined.Please note, per the instructions for use, 600419-004 version a, " the amplatzer duct occluder ii additional sizes is contraindicated for patients who weigh less than 6 kg and are younger than 6 months in age".
|
|
Event Description
|
It was reported through a research article identifying amplatzer ado ii may be related to a severe left pulmonary artery obstruction.Details are listed in the article, titled "device deformation and left pulmonary artery obstruction after transcatheter patent ductus arteriosus closure in preterm infants".It was reported in the article that in (b)(6) 2016, 14 patients underwent transcatheter patent ductus arteriosus (pda) closure.An 20 days old patient that weight 1672 grams with pda diameter of 2.95mm and pda length of 8.02mm was implanted with a 5-6 amplatzer ado ii.During follow up, aortic obstruction and severe left pulmonary artery obstruction was observed.The patient was asymptomatic and no intervention was performed.
|
|
Manufacturer Narrative
|
Correction information for d2
additional information for g4, g7, h2, h10.
|
|
Search Alerts/Recalls
|
|
|